48 Results

People

  1. O'Cearbhaill
    O'Cearbhaill
  2. Aghajanian
    Aghajanian
  3. Iasonos
    Iasonos
  4. Chi
    Chi
  5. Tew
    Tew
  6. Zhou
    Zhou
  7. Grisham
    Grisham
  8. Long Roche
    Long Roche
  9. Sonoda
    Sonoda
  10. Friedman
    Friedman

Groups

  1. Department of Medicine (48)
  2. GDMT, Medicine (48)
  3. Gynecologic Medicine Service (48)
  4. Gynecology Disease Management Team (48)
  5. Hematologic Malignancies, Division of (48)
  6. Solid Tumor Oncology Division (48)
  7. Epidemiology and Biostatistics (22)
  8. Biostatistics Service (21)
  9. Surgery (20)
  10. GDMT, Surgery (18)
  1. "female"
  2. "Hematologic Malignancies, Division of"
  3. "Gynecologic Medicine Service"
Formats
  1. Journal Article (46)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Medicine (48)
  2. GDMT, Medicine (48)
  3. Gynecologic Medicine Service (48)
  4. Gynecology Disease Management Team (48)
  5. Hematologic Malignancies, Division of (48)
  6. Solid Tumor Oncology Division (48)

More Groups

People
  1. Roisin O'Cearbhaill (37)
  2. Carol Aghajanian (17)
  3. Alexia Iasonos (16)
  4. Dennis Chi (14)
  5. Qin Zhou (14)
  6. William Tew (14)

More People

Years
  1. 2024 (2)
  2. 2023 (18)
  3. 2022 (7)
  4. 2021 (1)
  5. 2020 (8)
  6. 2019 (2)

More Years

Publications
  1. Gynecologic Oncology (23)
  2. Clinical Cancer Research (3)
  3. Gynecologic Oncology Reports (3)
  4. International Journal of Gynecological Cancer (2)
  5. JAMA Oncology (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (24)
  2. American Association for Cancer Research (3)
  3. Elsevier B.V. (3)
  4. Wiley Blackwell (3)
  5. American Medical Association (2)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer
    Journal Article

    Boerner, T.; Lam, C.; Basaran, D.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Long Roche, K.; Zivanovic, O.; Abu-Rustum, N. R.; Gardner, G. J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
    Journal Article

    Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Novel therapeutics in ovarian cancer: Expanding the toolbox
    Review

    Moufarrij, S.; O'Cearbhaill, R. E.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer: Results from the innovaTV 205/GOG-3024/ENGOT-cx8 study
    Journal Article

    Vergote, I.; Van Nieuwenhuysen, E.; O'Cearbhaill, R. E.; Westermann, A.; Lorusso, D.; Ghamande, S.; Collins, D. C.; Banerjee, S.; Mathews, C. A.; Gennigens, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: Results of a phase II study (MOONSTONE/GOG-3032)
    Journal Article

    Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; Gaillard, S.; Adams, S.; Duska, L. R.; Dalton, H.; Holloway, R. W.; Huang, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: Phase 1/2 trial interim results
    Journal Article

    Hassan, R.; Butler, M.; O’Cearbhaill, R. E.; Oh, D. Y.; Johnson, M.; Zikaras, K.; Smalley, M.; Ross, M.; Tanyi, J. L.; Ghafoor, A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Progression-free survival and safety at 3.5 years of follow-up: Results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
    Journal Article

    González-Martín, A.; Pothuri, B.; Vergote, I.; Graybill, W.; Lorusso, D.; McCormick, C. C.; Freyer, G.; Backes, F.; Heitz, F.; Redondo, A.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG Oncology/Gynecologic Oncology Group study 0283
    Journal Article

    O'Cearbhaill, R. E.; Miller, A.; Soslow, R. A.; Lankes, H. A.; DeLair, D.; Segura, S.; Chavan, S.; Zamarin, D.; DeBernardo, R.; Moore, K.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save